| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Rene Faber CEO | XFRA Exchange | 80386Y101 CUSIP |
| FR Country | 10,456 Employees | 1 Apr 2026 Last Dividend | - Last Split | - IPO Date |
Sartorius Stedim Biotech S.A., a prominent entity in the biopharmaceutical industry, is dedicated to manufacturing and distributing a vast range of instruments and consumables worldwide. Since its establishment in 1978 and headquartered in Aubagne, France, the company has been at the forefront of supporting the biopharmaceutical sector. Its clientele includes major manufacturers of medications, vaccines, foods, chemicals, and research and development laboratories. As of December 31, 2023, it functions under the umbrella of Sartorius AG, marking a significant affiliation that enhances its capabilities and service reach.